Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Medicine, Oncology, Internal medicine, Irinotecan, Epirubicin, and Gemcitabine.
Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
Correlation of response with progression-free (PFS) and overall (OS) survival in relapsed/refractory Ewing sarcoma (RR-ES): Results from the rEECur trial.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial